Chemical Compound Review:
Calypsol 2-(2-chlorophenyl)-2- methylamino...
Synonyms:
Cetamina, Ketaject, Ketanest, Ketoject, ketamine, ...
Krystal,
D'Souza,
Tramontozzi,
Weiner,
Gueorguieva,
Abi-Saab,
Limoncelli,
Lindahl,
Avila,
Lahti,
Weiler,
Miller,
Gueorguieva,
Charney,
Massie,
Krystal,
Belger,
Luckenbaugh,
Jatlow,
Abi-Dargham,
Boutros,
Krystal,
Carlson,
Charney,
Oren,
Manji,
Hu,
Schreiner,
Cooper,
Madonick,
Grant,
Tamminga,
Anand,
Singh,
Zarate,
Ameli,
Perry,
Trevisan,
Thaker,
Dean,
Brutsche,
Cappiello,
Petrakis,
Walker,
Krystal,
Berman,
Connor,
Macdougall,
Gelernter,
- Sedation in the intensive care unit: a systematic review. Ostermann, M.E., Keenan, S.P., Seiferling, R.A., Sibbald, W.J. JAMA (2000)
- The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Willert, R.P., Woolf, C.J., Hobson, A.R., Delaney, C., Thompson, D.G., Aziz, Q. Gastroenterology (2004)
- A ketamine-induced rat model of tardive dyskinesia. Marco, L.A., Joshi, R.S. Prog. Neurobiol. (1992)
- MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Sharp, F.R., Jasper, P., Hall, J., Noble, L., Sagar, S.M. Ann. Neurol. (1991)
- Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients. Marx, C.M., Stein, J., Tyler, M.K., Nieder, M.L., Shurin, S.B., Blumer, J.L. J. Clin. Oncol. (1997)
- The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Ellison, G. Brain Res. Brain Res. Rev. (1995)
- Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Honey, G.D., Honey, R.A., O'Loughlin, C., Sharar, S.R., Kumaran, D., Suckling, J., Menon, D.K., Sleator, C., Bullmore, E.T., Fletcher, P.C. Cereb. Cortex (2005)
- Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Petrakis, I.L., Limoncelli, D., Gueorguieva, R., Jatlow, P., Boutros, N.N., Trevisan, L., Gelernter, J., Krystal, J.H. The American journal of psychiatry. (2004)
- Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Umbricht, D., Koller, R., Vollenweider, F.X., Schmid, L. Biol. Psychiatry (2002)
- A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Zarate, C.A., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Arch. Gen. Psychiatry (2006)
- Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Corlett, P.R., Honey, G.D., Aitken, M.R., Dickinson, A., Shanks, D.R., Absalom, A.R., Lee, M., Pomarol-Clotet, E., Murray, G.K., McKenna, P.J., Robbins, T.W., Bullmore, E.T., Fletcher, P.C. Arch. Gen. Psychiatry (2006)
- Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Casadevall, M., Panés, J., Piqué, J.M., Marroni, N., Bosch, J., Whittle, B.J. Hepatology (1993)
- Protecting the ischemic spinal cord during aortic clamping. The influence of anesthetics and hypothermia. Naslund, T.C., Hollier, L.H., Money, S.R., Facundus, E.C., Skenderis, B.S. Ann. Surg. (1992)
- ECT stimulus intensity: are present ECT devices too limited? Krystal, A.D., Dean, M.D., Weiner, R.D., Tramontozzi, L.A., Connor, K.M., Lindahl, V.H., Massie, R.W. The American journal of psychiatry. (2000)
- Altered membrane properties of cerebral vascular smooth muscle following subarachnoid hemorrhage: an electrophysiological study. I. Changes in resting membrane potential (Em) and effect on the electrogenic pump potential contribution to Em. Waters, A., Harder, D.R. Stroke (1985)
- Measurement of regional brain glucose utilization in vivo using [2(-14)C] glucose. Hawkins, R., Hass, W.K., Ransohoff, J. Stroke (1979)
- Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B., Charney, D.S. Arch. Gen. Psychiatry (1994)
- Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes. Monaghan, D.T., Cotman, C.W. Proc. Natl. Acad. Sci. U.S.A. (1986)
- Pleural and pericardial pressures limit fetal right ventricular output. Grant, D.A., Walker, A.M. Circulation (1996)
- Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. Avila, M.T., Weiler, M.A., Lahti, A.C., Tamminga, C.A., Thaker, G.K. The American journal of psychiatry. (2002)
- Correlation of regional brain metabolism with receptor localization during ketamine anesthesia: combined autoradiographic 2-[3H]deoxy-D-glucose receptor binding technique. Hammer, R.P., Herkenham, M., Pert, C.B., Quirion, R. Proc. Natl. Acad. Sci. U.S.A. (1982)
- Inhibitory influence of frontal cortex on locus coeruleus neurons. Sara, S.J., Hervé-Minvielle, A. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Stimulus-based state control in the thalamocortical system. Miller, L.M., Schreiner, C.E. J. Neurosci. (2000)
- Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Moghaddam, B., Adams, B., Verma, A., Daly, D. J. Neurosci. (1997)
- Effect of anesthetic drugs on myocardial performance in man. Merin, R.G. Annu. Rev. Med. (1977)
- Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Anand, A., Charney, D.S., Oren, D.A., Berman, R.M., Hu, X.S., Cappiello, A., Krystal, J.H. Arch. Gen. Psychiatry (2000)
- Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Krystal, J.H., Perry, E.B., Gueorguieva, R., Belger, A., Madonick, S.H., Abi-Dargham, A., Cooper, T.B., Macdougall, L., Abi-Saab, W., D'Souza, D.C. Arch. Gen. Psychiatry (2005)
- Intracortical and corticothalamic coherency of fast spontaneous oscillations. Steriade, M., Amzica, F. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Long-term retention of learning-induced receptive-field plasticity in the auditory cortex. Weinberger, N.M., Javid, R., Lepan, B. Proc. Natl. Acad. Sci. U.S.A. (1993)
- Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Razoux, F., Garcia, R., Léna, I. Neuropsychopharmacology (2007)
- Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed-lineage kinase 3 via NMDA receptor-mediated Akt1 activation. Yin, X.H., Zhang, Q.G., Miao, B., Zhang, G.Y. J. Neurochem. (2005)
- Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs. Gratton, J.P., Rae, G.A., Claing, A., Télémaque, S., D'Orléans-Juste, P. Br. J. Pharmacol. (1995)
- Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine. Mudò, G., Jiang, X.H., Timmusk, T., Bindoni, M., Belluardo, N. Epilepsia (1996)
- Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. Narita, M., Yoshizawa, K., Nomura, M., Aoki, K., Suzuki, T. Eur. J. Pharmacol. (2001)
- Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Kawasaki, T., Ogata, M., Kawasaki, C., Ogata, J., Inoue, Y., Shigematsu, A. Anesth. Analg. (1999)
- A pervasive mechanism for analgesia: activation of GIRK2 channels. Blednov, Y.A., Stoffel, M., Alva, H., Harris, R.A. Proc. Natl. Acad. Sci. U.S.A. (2003)
- NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. Verma, A., Moghaddam, B. J. Neurosci. (1996)
- N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Albers, G.W., Goldberg, M.P., Choi, D.W. Ann. Neurol. (1989)